Browsing Tag
Natera Inc.
2 posts
Natera boosts ctDNA and lymphoma detection capabilities through Foresight Diagnostics acquisition
Find out how Natera’s acquisition of Foresight Diagnostics could redefine ultra-sensitive cancer detection and reshape the future of MRD testing.
Wall Street’s 25 top losers: Onto Innovation, Globus Medical, Affirm dive as investors exit growth stocks
Discover why Onto Innovation, Globus Medical, and Affirm led 25 major U.S. stock declines on May 9, 2025, amid sector stress and hawkish Fed signals.